Journals / Klinik Psikiyatri Dergisi / 2017 / Cilt: 20 - Sayı: 2

Epilepsy and Stigmatization: A review

Epilepsi ve Damgalanma: Bir Gözden Geçirme

Pages
129–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this article is to increase the awarenessof stigmatization that hampers the treatment and quality of life of epilepsy patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epilepsy, which is considered dangerous and scary by thesociety, is a frequent neurological disease.
📊
Key Findings & Data:Althoughepileptic seizures can be controlled with drugs, prejudices towards this disease being scary still continue.There are several factors that determine the level ofstigmatization directed to epilepsy.
💡
Conclusion & Impact:The aim of this article is to increase the awarenessof stigmatization that hampers the treatment and quality of life of epilepsy patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Epilepsy, which is considered dangerous and scary by thesociety, is a frequent neurological disease. Althoughepileptic seizures can be controlled with drugs, prejudices towards this disease being scary still continue.There are several factors that determine the level ofstigmatization directed to epilepsy. Age, marital status,education of the patient, age of disease onset, thetreatment duration of the disease, drug side effects,accompanying physical and psychiatric disorders, education level of those stigmatizing and disease-relatedknowledge level are among these factors. Adverse outcomes are observed in many areas such as quality of life,treatment complience, social and occupational functionality. The aim of this article is to increase the awarenessof stigmatization that hampers the treatment and quality of life of epilepsy patients

Özet

Toplum tarafından tehlikeli ve ürkütücü olduğu düşünülen epilepsi, sık görülen nörolojik bir hastalıktır. Kullanılan ilaçlarla epileptik nöbetler yüksek oranda kontrol altına alınsa bile, bu hastalığa yönelik korkutucu ön yargılar halen devam etmektedir. Epilepsiye yönelik damgalanmanın düzeyini etkileyen bir çok faktör vardır. Hasta yaşı, medeni durumu, eğitim durumu, hastalığın başlangıç yaşı, tedavi süresi, ilaç yan etkileri, eşlik eden fiziksel ve psikiyatrik bozukluklar, damgalayanların eğitim düzeyleri, hastalık hakkında bilgi düzeyleri bu faktörler arasında sayılabilir. Damgalanmanın hastanın yaşam kalitesi, tedaviye uyumu, sosyal ve mesleki işlevselliği gibi alanlarda olumsuz sonuçları gözlenmektedir. Bu yazının amacı, epilepsi hastalarının tedavisini zorlaştıran ve yaşam kalitelerini bozan damgalanma hakkında farkındalığı arttırmaktır.

🔖

Cite This Article

AY, R. (2017). Epilepsy and Stigmatization: A review. Klinik Psikiyatri Dergisi, Cilt: 20 - Sayı: 2, 129–136. https://ajindex.com/articles/198706

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Schulze B, Angermeyer MC. Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med 2003; 56(2): 299-312
  2. Yýldýrým Z. Türk toplumunda epilepsi ve stigmanýn deðerlendirilmesi, epilepsi hastalarýnda stigma ve depresyonun iliþ- kisinin araþtýrýlmasý. Bakýrköy ruh saðlýðý ve sinir hastalýklarý eðitim ve araþtýrma hastanesi. Uzmanlýk tezi. 2016
  3. Üçok A. Þizofreni: Stigma, mitler ve gerçekler. Psikiyatri Dünyasý 1999; 3:67-71
  4. Link BG, Phelan JC. On stigma and its public health implications. Paper presented at US NIH conference on stigma and global health: developing a research agenda, Bethesda MD.(2001) http://www.stigmaconference.nih.gov (accessed oct, 2016
  5. Link BG. Understanding labelling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. AM Sociol Rev 1987; 52: 96-112 6. Scambler G, Hopkins A. Generating a model of epileptic stigma: the role ofqualitative analysis. Soc Sci Med 1990; 30: 1187- 1194
  6. Jacoby A, Austin JK. Social stigma for adults and children with epilepsy. Epilepsia 2007; 48(9): 6-9. 8.Aydemir N, Ozkara C, Unsal P, Canbeyli R. A comparative study of health related quality of life, psychological well-being, impact of illness and stigma in epilepsy and migraine. Seizure 2011; 20: 679-685
  7. Baker GA, Jacoby A, Buck D, Brooks J, Potts P, Chadwick DW. The quality of life of older people with epilepsy: findings from a UK community study. Seizure 2001; 10(2): 92-99
  8. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997; 38(2): 233-236
  9. Fiest KM, Birbeck GL, Jacoby A, Jette N. Stigma in epilepsy. Curr Neurol Neurosci Rep 2014; 14(5): 444
  10. Jacoby A, Snape D, Baker GA. Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol 2005; 4(3): 171-178
  11. Herrmann LK, Welter E, Berg AT, Perzynski AT, Van Doren JR, Sajatovic M. Epilepsy misconceptions and stigma reduction: Current status in Western countries. Epilepsy Behav 2016; 60: 165-173
  12. Dawkins JL, Crawford PM, Stammers TG. Epilepsy: a general practice study of knowledge and attitudes among sufferers and non-sufferers. Br J Gen Pract 1993; 43(376): 453-457
  13. Doughty J, Baker GA, Jacoby A, Lavaud V. Cross-cultural differences in levels of knowledge about epilepsy. Epilepsia 2003; 44(1):115-123